RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,233,946 | -29.2% | 384,536 | +5.7% | 0.00% | -33.3% |
| Q2 2023 | $4,570,368 | +15.7% | 363,883 | +51.4% | 0.00% | 0.0% |
| Q1 2023 | $3,950,553 | +20.5% | 240,381 | +9.6% | 0.00% | 0.0% |
| Q4 2022 | $3,277,312 | -33.1% | 219,365 | +0.2% | 0.00% | -25.0% |
| Q3 2022 | $4,900,000 | +32.3% | 219,035 | -0.9% | 0.00% | +33.3% |
| Q2 2022 | $3,703,000 | -39.6% | 221,084 | +7.9% | 0.00% | -25.0% |
| Q1 2022 | $6,132,000 | -2.5% | 204,883 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,290,000 | +0.7% | 204,822 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $6,245,000 | -13.8% | 198,067 | +0.0% | 0.00% | -20.0% |
| Q2 2021 | $7,245,000 | +83.2% | 198,004 | +73.1% | 0.01% | +66.7% |
| Q1 2021 | $3,954,000 | -18.2% | 114,385 | -1.6% | 0.00% | -25.0% |
| Q4 2020 | $4,832,000 | -8.2% | 116,275 | -5.9% | 0.00% | -20.0% |
| Q3 2020 | $5,262,000 | – | 123,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |